188 related articles for article (PubMed ID: 1090427)
1. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of pipothiazine and its palmitic ester in the therapy of schizophrenia].
Costa JG; Silva E; Dreyfus JF
Ann Med Psychol (Paris); 1981 Apr; 139(4):439-45. PubMed ID: 6118086
[TBL] [Abstract][Full Text] [Related]
3. Uncontrolled study with pipothiazine palmitate.
Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
[No Abstract] [Full Text] [Related]
4. [Initial results of a pharmacokinetic study of pipothiazine and its palmitic ester (Piportil L4) in a schizophrenic population].
Girard M; Granier F; Schmitt L; Cotonat J; Escande M; Blanc M
Encephale; 1984; 10(4):171-6. PubMed ID: 6149927
[TBL] [Abstract][Full Text] [Related]
5. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
Donlon PT; Rada RT
Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
[TBL] [Abstract][Full Text] [Related]
6. Depot pipotiazine 1970-1982: a review.
Burch EA; Ayd FJ
J Clin Psychiatry; 1983 Jul; 44(7):242-7. PubMed ID: 6134718
[TBL] [Abstract][Full Text] [Related]
7. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
Salvesen C; Vaksdal K
Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
[No Abstract] [Full Text] [Related]
8. Pipotiazine palmitate: a new depot neuroleptic.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1975 Mar; 17(3):276-80. PubMed ID: 236151
[No Abstract] [Full Text] [Related]
9. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Brook S
J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
[TBL] [Abstract][Full Text] [Related]
10. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
12. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
Robak OH
Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
[No Abstract] [Full Text] [Related]
13. Penfluridol: a long acting oral antipsychotic drug.
Claghorn JL; Mathew RJ; Mirabi M
J Clin Psychiatry; 1979 Feb; 40(2):107-9. PubMed ID: 368045
[TBL] [Abstract][Full Text] [Related]
14. A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice.
Johnston RE; Niesink F
J Int Med Res; 1979; 7(3):187-93. PubMed ID: 37133
[TBL] [Abstract][Full Text] [Related]
15. Clinical experiments with the new oral long-acting neuroleptic clopimozide (R 29 764).
Floru L; Tegeler J
Arzneimittelforschung; 1978; 28(2):341-4. PubMed ID: 25071
[TBL] [Abstract][Full Text] [Related]
16. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
19. Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia.
Gopal S; Gassmann-Mayer C; Palumbo J; Samtani MN; Shiwach R; Alphs L
Curr Med Res Opin; 2010 Feb; 26(2):377-87. PubMed ID: 20001492
[TBL] [Abstract][Full Text] [Related]
20. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
